Morphine Market size was over USD 17.27 billion in 2024 and is projected to reach USD 40.13 billion by 2037, growing at around 6.7% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of morphine is assessed at USD 18.2 billion. The growth of this market can be attributed to the back of high prevalence of chronic diseases and orthopedic health issues raising the demand for morphine in the pain management sector. As per the estimates, by 2050 around 130 million people are expected to suffer from osteoarthritis out of which 40 million will be physically disabled across the globe.
People's lifestyle changes causing pain and the increasing number of surgical procedures may also drive the expansion of this morphine market. As a result of increased pain post-surgery, morphine is a common drug prescribed to patients after surgery to ease surgical pain.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.7% |
|
Base Year Market Size |
USD 17.27 billion |
|
Forecast Year Market Size |
USD 40.13 billion |
|
Regional Synopsis |
|
Application (Pain Management, Diarrhea Suppressant)
In application segmentation, the pain management segment is predicted to dominate the morphine market with a share of 69 percent by the end of 2037. If the patient's pain cannot be managed with regular pain relievers, then the patient is prescribed morphine sustained-release tablets to relieve severe pain. Opioids play an important role in ensuring adequate analgesia in acute postoperative situations. The presence of ailments such as cancer, and other diseases has increased the demand for morphine in ​​pain management. In a study, it was reported that almost 20% of doctors prescribe opioids such as morphine to patients admitted to the emergency ward.
Mode of Administration (Injection, Oral)
In terms of mode of administration, the oral segment in the morphine market is expected to observe the highest CAGR during the time period between 2023 – 2037. The oral segment includes morphine in oral tablet and pharmaceutical form. The immediate effect of the oral tablets is within 30 to 60 minutes due to which it is mostly opted by the patients. Moreover, oral morphine provides short as well as long-term severe pain through the capsule and extended-release tablet. Also, it is considered one of the easiest ways that can be taken by the patients themselves.
Our in-depth analysis of the global morphine market includes the following segments:
|
Application |
|
|
Mode of Administration |
|
North American Market Statistics
The morphine market in the North America region is projected to observe the largest market revenue with a share of 35 percent throughout 2023 - 2037. This can be attributed to the increasing patient pool of osteoporosis. According to the statistics of the Centers for Disease Control and Prevention, 4.2% of men and 18.8% of women over the age of 50 years suffered from osteoporosis of the femur neck or lumbar spine. Moreover, a high share of the geriatric population in countries, such as the United States and Canada, is estimated to boost the regional market growth. In addition, a rise in research collaboration numbers is among the factors anticipated to boost market expansion. Due to its pro-healthcare legislation, the United States has the largest share in this area.
APAC Market Analysis
In Asia Pacific, the morphine sector is assumed to witness a substantial market extension of 28 percent by the end of 2037. The increasing investment in the healthcare sector and rising awareness about palliative care medication in the region are expected to drive market growth in the Asia Pacific region. Some countries such as India, and China have well-developed healthcare infrastructure with proper pain management medications such as morphine use, but at the same time, few regions still working on implementing these chronic disease management solutions that include chronic pain management in the region. As per the India Brand Equity Foundation, the government of India is planning to launch a credit incentive program to boost the healthcare infrastructure accounting for USD 6.8 billion.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?